Development and validation of a sensitive spectrofluorimetric method for the determination of cilazapril of human plasma, urine, in pure and pharmaceutical preparations

Loading...
Thumbnail Image

Date

2015

Journal Title

Journal ISSN

Volume Title

Publisher

Maik Nauka/Interperiodica/Springer

Access Rights

info:eu-repo/semantics/closedAccess

Abstract

A selective and sensitive spectrofluorimetric method was developed and validated for the determination of cilazapril in human plasma urine, in pure and pharmaceutical preparations. The proposed method is based on derivatization using 1-dimethylaminonaphthalene-5-sulphonyl chloride (dansyl chloride) as fluorogenic agent and measuring the fluorescence of the products at emission wavelengths of 503 nm after excitation at 374 nm. The method was validated for linearity, limit of detection, limit of quantification, precision, accuracy, recovery. The calibration curves were linear over a concentration range of 100-500 and 50-250 ng/mL for plasma and urine, respectively. The limits of detection were calculated to be 0.26 and 31.59 ng/mL for plasma and urine, respectively. The proposed method was applied to study of cilazapril in pure, human plasma, urine, and pharmaceutical preparations.

Description

Keywords

Performance Liquid-Chromatography, Active Metabolite Cilazaprilat, Enzyme-Inhibitor Cilazapril, Quantitative-Determination, Hydrochlorothiazide, Formulations

Journal or Series

Optics and Spectroscopy

WoS Q Value

Q4

Scopus Q Value

Q4

Volume

119

Issue

2

Citation